Solid Tumor
Empowering oncology
through precision diagnostics
Built around the patient.
Scaled for your lab.
Every cancer patient is genetically unique. This diversity is the key to truly personalized care. Our molecular testing solutions are designed to capture this complexity and turn it into actionable insights, for any lab, starting from any sample.
Precise
Our solutions combine standardized workflows and high analytical sensitivity to detect all clinically relevant variants, even in challenging samples, supporting accurate, personalized care for every patient.
Fast
Our solutions deliver critical molecular results in time to guide early treatment decisions, helping cancer patients begin the right therapy without delay when it matters most.
Actionable
Our tools offer clinically meaningful results that can directly support diagnosis, prognosis, and therapeutic strategy, enabling personalized care at every step of the patient’s journey.
Discover our complete solutions for the molecular profiling of solid tumors
EasyPGX®
The dry qPCR revolution against cancer
EasyPGX® is the ready-to-use RT-PCR testing solution with the most comprehensive portfolio of IVD assays dedicated to precision oncology.
Ready to use
Complete portfolio
Regulatory compliant
EasyPGX® workflow
Enhance your diagnostic routine to accelerate personalized medicine
Nucleic Acid extraction
PCR setup
Add extracted samples to ready-to-use 8-well strip
<5 min
TURNAROUND TIME
<5 min
HANDS-ON
PCR run
Load the strip onto the thermal-cycler and start the run
90 min
TURNAROUND TIME
<1 min
HANDS-ON
Data analysis
Import raw data into the EasyPGX® Analysis Software
<1 min
TURNAROUND TIME
<1 min
HANDS-ON
Made for challenging samples
Easy-to-use
Flexible
Fast
Explore EasyPGX® comprehensive biomarker portfolio for precision oncology
The EasyPGX® assay portfolio includes all the main clinically relevant routine biomarkers for the most common solid tumours, in accordance with the leading international guidelines.
KRAS, BRAF, NRAS,
RET, HRAS, PPARG
KRAS, BRAF, EGFR,
ALK, ROS1, RET, MET
KRAS, BRAF, NRAS,
MSI, MLH1, РІКЗСА
FGFR2-3
BRAF, NRAS
KRAS, BRAF, EGFR,
NRAS, PIK3CA, ESR1
DPYD, UGT1A1
MSI, NTRK,
RET, BRAF
HPV, HRAS
IDH1-2, FGFR2,
KRAS, BRAF
HPV, MSI, MLH1
РІКЗСА, ESR1
BRAF, IDH1-2,
MGMT
Thyroid Cancer
KRAS, BRAF, NRAS, RET, HRAS, PPARG
Non-Small Cell Lung Cancer
KRAS, BRAF, EGFR, ALK, ROS1, RET, MET
Colorectal Cancer
KRAS, BRAF, NRAS, MSI, MLH1, РІКЗСА
Urothelial Cancer
FGFR2-3
Melanoma
BRAF, NRAS
Liquid Biopsy Assays
KRAS, BRAF, EGFR, NRAS, PIK3CA, ESR1
Pharmaco-genetic
DPYD, UGT1A1
Tumour-Agnostic Biomarkers
MSI, NTRK, RET, BRAF
Head and Neck Cancer
HPV, HRAS
Head and Neck Cancer
HPV, HRAS
Cholangio-carcinoma
IDH1-2, FGFR2, KRAS, BRAF
Gynecologic Cancers
HPV, MSI, MLH1
Breast
Cancer
РІКЗСА, ESR1
Glioma
BRAF, IDH1-2, MGMT
EasyPGX® Analysis Software
Streamline your data analysis process
- No cloud or external data sharing required
- Automated variant calling and raw data checking combined in a single software solution.
- data export and reporting available in various common file formats.
Myriapod® NGS
Complexity made easy
Myriapod® is the advanced NGS-based diagnostic solution for detecting clinically relevant genomic variants in precision oncology.
Comprehensive
Easy & Fast
Regulatory compliant
Adapting to your lab,
advancing care for your patients
Built for today’s clinical challenges, Myriapod® NGS portfolio offers the flexibility to meet diverse needs, from targeted tests to comprehensive insights. Scalable and precise, it helps bring personalized answers to every cancer patient, at every step, everywhere.
Clinically
approved
biomarkers
targeted testing
- Focus on clinically approved biomarkers
- Low multigene testing diseases
- Fast and simple workflow
High-plex multigene
cancer testing
- Medium to high multigene testing diseases
- Actionable and fast results
- Including clinical and preclinical targets
Genomic Comprehensive
Profile
- Second level advanced testing
- Rare tumors
- Clinical trail and transliational research
Clinically approved biomarkers targeted testing
- Focus on clinically approved diagnostic biomarkers
- Low multigene testing disease
- Fast results
High-plex multigene cancer testing
- High-plex genes testing
- Comprehensive biomarkers content
- Including clinical and pre clinical targets
Genomic Comprehensive Profile
- Second level advanced testing
- Rare tumors
- Clinical trail and transliational research
Ready to use reagents
TAT <4 days
Sample flexibility
On-premise
data analysis
Flexible throughput
Low imput
Myriapod® NGS Data Analysis
On-Premise Bioinformatics for Clinical Genomics
The Myriapod NGS Data Analysis suite is a robust, on-premise bioinformatics solution combining a high-performance workstation with proprietary software for streamlined NGS data processing, even in an environment without bioinformatics expertise
- Smart Variant Analysis: SNVs, InDels, CNV, Fusions, MSI, HRD & HRR automatically identified – no bioinformatics expertise needed.
- Total Data Protection: 100% local processing. No cloud. No external servers. No compromises.
- QC You Can Trust: Automatic run and sample validation, every time.
- Built-In Intelligence: Variants classified using trusted genomic databases.